Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Sep;30(9):2230–2234. doi: 10.1128/jcm.30.9.2230-2234.1992

Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children.

E L Anderson 1, F K Newman 1, H F Maassab 1, R B Belshe 1
PMCID: PMC265484  PMID: 1400985

Abstract

A cold-adapted (ca) influenza B reassortant virus vaccine that contained the six internal RNA segments from influenza B/Ann Arbor/1/66 ca virus and the neuraminidase and hemagglutinin genes from wild-type influenza B/Texas/1/84 virus was evaluated in children ranging in age from 8 months to 14 years. The children were vaccinated intranasally with doses ranging from 10(3.2) to 10(6.2) 50% tissue culture infective doses (TCID50). Thirty children were seropositive, and 26 were seronegative. Thirty-three children participated as unvaccinated controls. The vaccine was well tolerated by both seronegative and seropositive children. The amount of virus required to infect 50% of seronegative children was approximately 10(4.5) TCID50. Vaccine viruses recovered from airway secretions retained temperature-sensitive and cold-adapted characteristics. The results of this study indicate that the vaccine virus, influenza B/Texas/84 ca reassortant virus, is attenuated, immunogenic, and phenotypically stable when given to young seronegative children.

Full text

PDF
2230

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. L., Belshe R. B., Burk B., Bartram J., Maassab H. F. Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants. J Clin Microbiol. 1989 May;27(5):909–914. doi: 10.1128/jcm.27.5.909-914.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baine W. B., Luby J. P., Martin S. M. Severe illness with influenza B. Am J Med. 1980 Feb;68(2):181–189. doi: 10.1016/0002-9343(80)90352-6. [DOI] [PubMed] [Google Scholar]
  3. Belshe R. B., Van Voris L. P. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge. J Infect Dis. 1984 May;149(5):735–740. doi: 10.1093/infdis/149.5.735. [DOI] [PubMed] [Google Scholar]
  4. Clements M. L., Snyder M. H., Sears S. D., Maassab H. F., Murphy B. R. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. J Infect Dis. 1990 May;161(5):869–877. doi: 10.1093/infdis/161.5.869. [DOI] [PubMed] [Google Scholar]
  5. Cox N. J., Maassab H. F., Kendal A. P. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Virology. 1979 Aug;97(1):190–194. doi: 10.1016/0042-6822(79)90386-6. [DOI] [PubMed] [Google Scholar]
  6. Davenport F. M., Hennessy A. V., Maassab H. F., Minuse E., Clark L. C., Abrams G. D., Mitchell J. R. Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. J Infect Dis. 1977 Jul;136(1):17–25. doi: 10.1093/infdis/136.1.17. [DOI] [PubMed] [Google Scholar]
  7. Dietzman D. E., Schaller J. G., Ray C. G., Reed M. E. Acute myositis associated with influenza B infection. Pediatrics. 1976 Feb;57(2):255–258. [PubMed] [Google Scholar]
  8. Edwards K. M., King J. C., Steinhoff M. C., Thompson J., Clements M. L., Wright P. F., Murphy B. R. Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children. J Infect Dis. 1991 Apr;163(4):740–745. doi: 10.1093/infdis/163.4.740. [DOI] [PubMed] [Google Scholar]
  9. Foy H. M., Cooney M. K., Allan I. Longitudinal studies of types A and B influenza among Seattle schoolchildren and families, 1968-74. J Infect Dis. 1976 Oct;134(4):362–369. doi: 10.1093/infdis/134.4.362. [DOI] [PubMed] [Google Scholar]
  10. Glezen W. P., Couch R. B., Taber L. H., Paredes A., Allison J. E., Frank A. L., Aldridge C. Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol. 1980 Jan;111(1):13–22. doi: 10.1093/oxfordjournals.aje.a112865. [DOI] [PubMed] [Google Scholar]
  11. Hall C. B., Douglas R. G., Jr, Geiman J. M., Meagher M. P. Viral shedding patterns of children with influenza B infection. J Infect Dis. 1979 Oct;140(4):610–613. doi: 10.1093/infdis/140.4.610. [DOI] [PubMed] [Google Scholar]
  12. Keitel W. A., Couch R. B., Cate T. R., Six H. R., Baxter B. D. Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge. J Infect Dis. 1990 Jan;161(1):22–26. doi: 10.1093/infdis/161.1.22. [DOI] [PubMed] [Google Scholar]
  13. Klein J. D., Collier A. M., Glezen W. P. An influenza B epidemic among children in day-care. Pediatrics. 1976 Sep;58(3):340–345. [PubMed] [Google Scholar]
  14. LaMontagne J. R. From the National Institute of Allergy and Infectious Diseases: summary of a workshop on influenza B viruses and Reye's syndrome. J Infect Dis. 1980 Sep;142(3):452–465. doi: 10.1093/infdis/142.3.452. [DOI] [PubMed] [Google Scholar]
  15. Maassab H. F., DeBorde D. C. Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine. 1985 Dec;3(5):355–369. doi: 10.1016/0264-410x(85)90124-0. [DOI] [PubMed] [Google Scholar]
  16. Marchant C. D., Shurin P. A., Turczyk V. A., Wasikowski D. E., Tutihasi M. A., Kinney S. E. Course and outcome of otitis media in early infancy: a prospective study. J Pediatr. 1984 Jun;104(6):826–831. doi: 10.1016/s0022-3476(84)80475-8. [DOI] [PubMed] [Google Scholar]
  17. Monto A. S., Miller F. D., Maassab H. F. Evaluation of an attenuated, cold-recombinant influenza B virus vaccine. J Infect Dis. 1982 Jan;145(1):57–64. doi: 10.1093/infdis/145.1.57. [DOI] [PubMed] [Google Scholar]
  18. Serwint J. R., Miller R. M., Korsch B. M. Influenza type A and B infections in hospitalized pediatric patients. Who should be immunized? Am J Dis Child. 1991 Jun;145(6):623–626. doi: 10.1001/archpedi.1991.02160060041017. [DOI] [PubMed] [Google Scholar]
  19. Steinhoff M. C., Halsey N. A., Fries L. F., Wilson M. H., King J., Burns B. A., Samorodin R. K., Perkis V., Murphy B. R., Clements M. L. The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. J Infect Dis. 1991 May;163(5):1023–1028. doi: 10.1093/infdis/163.5.1023. [DOI] [PubMed] [Google Scholar]
  20. Steinhoff M. C., Halsey N. A., Wilson M. H., Burns B. A., Samorodin R. K., Fries L. F., Murphy B. R., Clements M. L. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children. J Infect Dis. 1990 Aug;162(2):394–401. doi: 10.1093/infdis/162.2.394. [DOI] [PubMed] [Google Scholar]
  21. Van Voris L. P., Belshe R. B., Shaffer J. L. Nosocomial influenza B virus infection in the elderly. Ann Intern Med. 1982 Feb;96(2):153–158. doi: 10.7326/0003-4819-96-2-153. [DOI] [PubMed] [Google Scholar]
  22. Wald E. R., Guerra N., Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics. 1991 Feb;87(2):129–133. [PubMed] [Google Scholar]
  23. Wright P. F., Bryant J. D., Karzon D. T. Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis. 1980 Apr;141(4):430–435. doi: 10.1093/infdis/141.4.430. [DOI] [PubMed] [Google Scholar]
  24. Wright P. F., Karzon D. T. Live attenuated influenza vaccines. Prog Med Virol. 1987;34:70–88. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES